AbbVie (ABBV)

$166.17 0.18 (0.11%)

10:02 EST ABBV Stock Quote Delayed 30 Minutes

The 7 Most Undervalued Value Stocks to Buy Now

By Alex Sirois Dec 8, 2022

The search for undervalued value stocks has become more difficult, but there is still value to be found if you know where to look.

The 7 Best Dividend Stocks to Buy for Your Grandkids in 2023

3 Dividend Stocks to Buy in Case the Santa Rally Doesn’t Come

7 No-Brainer Dividend Stocks to Buy for 2023 and Beyond

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 596,677

Day's Range $166.04 - $167.75

52-Week Range $120.75 - $175.91

Dividend & Yield $5.20 (3.13%)

ABBV Stock Predictions, Articles, and AbbVie News

From InvestorPlace
From the Web

The 7 Best Pharma Stocks to Buy Now

By Joel Baglole, InvestorPlace Contributor Nov 8, 2022

Oil and natural gas stocks are not the only ones to post big gains this year. Several pharmaceutical stocks have rallied 30% or more as sales of their blockbuster medications, including Covid-19 vaccines, supercharge their earnings.

The 7 Most Popular Dividend Stocks Ranked from Biggest to Smallest

By Chris Markoch, InvestorPlace Contributor Oct 28, 2022

This article will give you seven of the most popular dividend stocks ranked from the largest market cap to the smallest

Steal Some Yield and Bet on Clinical Clout With ABBV Stock

By Louis Navellier and the InvestorPlace Research Staff Oct 27, 2022

ABBV stock investors can collect dividend payments but also expect share-price upside as AbbVie continues to clear regulatory hurdles.

4 Dividend Stocks Yielding 4%+

By Prakash Kolli Oct 11, 2022

Dividend stocks provide an excellent source of passive income. Check out these four stocks with yields of more than 4%.

These 7 Biotech Stocks Are Set to Boom in 2023

By Chris Markoch, InvestorPlace Contributor Oct 10, 2022

This article looks at seven biotech stocks that look like good options to move significantly higher in 2023

7 Growth Stocks to Buy and Hold for the Next 10 Years

By Chris Lau, InvestorPlace Contributor Oct 7, 2022

The bear market is unfriendly to growth stocks but creates a better buying price for investors -- and long-term gains.

Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?

By Bob Ciura, Sure Dividend Oct 5, 2022

ABBV stock has rightly earned its place among the Best Stocks for 2022. This Dividend King is outperforming the S&P 500.

3 Cheap Stocks to Buy for Their High Cash Flow and Dividends

By Bret Kenwell, InvestorPlace Contributor Oct 4, 2022

Amid a bear market, investors want cheap stocks with high dividend yields and strong free cash flow. Here are three that fit the bill.

7 Top-Rated Biotech Stocks to Buy for Q4

By Louis Navellier and the InvestorPlace Research Staff Sep 15, 2022

A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.

7 S&P 500 Stocks to Buy With Superior Fundamentals

By Josh Enomoto, InvestorPlace Contributor Sep 8, 2022

With the market and the broader economy poised for significant changes, investors may find confidence in S&P 500 stocks to buy.

7 Top-Rated Large-Cap Stocks to Buy and Hold

By Louis Navellier and the InvestorPlace Research Staff Aug 23, 2022

As the stock market remains in choppy waters, consider these seven top-rated, large-cap stocks. Each one earns either an "A" or "B" rating in my Portfolio Grader.

7 Blue-Chip Stocks That Will Survive 2022

By Tezcan Gecgil, InvestorPlace Contributor Aug 9, 2022

These are among the best blue-chip stocks to buy now. Here's why ABBV, BDX, CI, DD, MMM, JPM, and PFE can make great investments.

ABBV Stock Slips as AbbVie Faces Opioid Lawsuits

By David Moadel, InvestorPlace Contributor Jul 29, 2022

AbbVie's quarterly results were roughly in line with Wall Street's expectations, but ABBV stock still slipped in early trading.

7 Blue-Chip Stocks to Buy on the Dip

By Alex Sirois Jul 27, 2022

These 7 blue-chip stocks to buy on the dip are very unlikely to cause investors any regrets through 2022 and beyond.

7 Value Stocks Trading at a Massive Discount Right Now

By Muslim Farooque, InvestorPlace Contributor Jul 24, 2022

These value stocks trading at discount are trading at attractive valuations while their fundamentals continue to impress.

7 Best Income Stocks to Buy Now

By Josh Enomoto, InvestorPlace Contributor Jul 20, 2022

With inflation putting a beating on household budgets and earnings, the best income stocks to buy may help mitigate the crisis.

$192 Price Target Makes AbbVie Stock a Notable Healthcare Pick

By Louis Navellier and the InvestorPlace Research Staff Jul 18, 2022

ABBV stock could have substantial room to run as a big-bank analyst assigns a high rating to relentlessly innovative AbbVie.

Best Stocks for 2022: After Two Quarters, Who Holds The Lead?

By Avril Ayers, Web Editor Jul 17, 2022

After the first two quarters of fiscal year 2022, who holds the top spot in the InvestorPlace Best Stocks for 2022 contest? Let's dive in.

7 Overlooked Blue-Chip Stocks to Add to Your Buy List

By Josh Enomoto, InvestorPlace Contributor Jul 11, 2022

With investors seeking viable ideas during this strange time, overlooked blue-chip stocks to buy could offer stable contrarian upside.

Best Stocks for 2022: AbbVie Is a Recession-Resistant Dividend King

By Bob Ciura, Sure Dividend Jul 7, 2022

ABBV stock is one of the best choices you can make for 2022. Even though the company is losing its Humira patent soon, it isn't slowing down.

AbbVie (ABBV)

The 7 Most Undervalued Value Stocks to Buy Now

The 7 Best Dividend Stocks to Buy for Your Grandkids in 2023

3 Dividend Stocks to Buy in Case the Santa Rally Doesn’t Come

7 No-Brainer Dividend Stocks to Buy for 2023 and Beyond

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AbbVie (ABBV)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ABBV Stock Predictions, Articles, and AbbVie News

Subscriber Sign in